Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0AHCYZ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
WO2022228495A1 ADC-77
|
|||||
| Synonyms |
WO2022228495A1-ADC-77
Click to Show/Hide
|
|||||
| Organization |
Shanghai Huilun Pharmaceutical Co., Ltd.
|
|||||
| Drug Status |
Investigative
|
|||||
| Indication |
In total 2 Indication(s)
Breast cancer [ICD11:2C60-2C65]
Investigative
Lung squamous cell carcinoma [ICD11:2C25]
Investigative
|
|||||
| Drug-to-Antibody Ratio |
4.2
|
|||||
| Antibody Name |
Sacituzumab
|
Antibody Info | ||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TACSTD2)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
WO2022228495A1 ADC-77 linker
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.